Understanding Inhalation Dev

An inhalation device is a sophisticated medical tool engineered to

deliver medication directly into the respiratory tract, targeting the
lungs with precision and efficacy. These devices represent a
cornerstone of modern respiratory medicine, providing immediate
relief and long-term management for millions of patients
worldwide suffering from conditions such as asthma, chronic
obstructive pulmonary disease (COPD), bronchitis, and other
chronic respiratory ailments. By bypassing the gastrointestinal
system and delivering medication straight to the site of action,
inhalation devices offer a targeted therapeutic approach that
maximises drug efficacy whilst minimising unwanted systemic side
effects.
The Critical Importance of Inhalation Therapy
Why Direct Delivery Matters
The inhalation route represents a paradigm shift in
respiratory medication delivery. Unlike oral medications
that must traverse the digestive system, undergo hepatic
metabolism, and then circulate systemically before reaching
the lungs, inhaled medications arrive directly at their target
tissue within seconds. This localised delivery mechanism
allows for dramatically lower doses—often 10 to 100 times
less than equivalent oral formulations—whilst achieving
superior therapeutic concentrations in the bronchial airways
and lung parenchyma.
The physiological advantages are profound: rapid symptom
relief during acute bronchospasm, reduced systemic drug
exposure minimising adverse effects such as cardiovascular
complications or metabolic disturbances, and improved
patient compliance due to faster perceived benefit. For
conditions requiring chronic daily therapy, the reduced
systemic burden translates to a significantly improved
safety profile over months and years of treatment.
Types of Inhalation Devices
The landscape of inhalation devices encompasses four primary categories, each with distinct
mechanisms, advantages, and clinical applications. Understanding these differences is essential for
appropriate device selection tailored to individual patient characteristics, disease severity, cognitive
ability, and coordination skills.

Metered Dose Inhaler (MDI) Dry Powder Inhaler (DPI)

A pressurised canister system delivering a precisely A breath-activated device containing medication in

measured dose of medication as an aerosol spray. dry powder form, eliminating the need for
The gold standard for decades, widely available and propellants and requiring the patient's inspiratory
cost-effective. effort to disperse the drug.

Soft Mist Inhaler (SMI) Nebulizer

An advanced device producing a fine, slow-moving

mist that enhances lung deposition through
An electrically powered device converting liquid
improved particle size and velocity characteristics.
medication into a continuous inhalable aerosol mist,
ideal for those unable to use handheld devices
effectively.
 Metered Dose Inhaler (MDI)
Device Characteristics and Clinical Use
The Metered Dose Inhaler remains one of the most
widely prescribed inhalation devices globally, utilising
a pressurised canister containing medication
suspended or dissolved in a hydrofluoroalkane (HFA)
propellant. When actuated, the device releases a
precisely measured dose—typically between 50 to 250
micrograms depending on the medication—in the form
of a high-velocity aerosol spray.
Key operational features include:

• Compact, portable design suitable for pocket or handbag storage

• Consistent dose delivery across 100-200 actuations per canister

• Requires coordination between manual actuation and inhalation timing
• Often prescribed with a valved holding chamber (spacer) to
improve drug delivery and reduce oropharyngeal
deposition
• Suitable for most patients when technique is mastered Clinical Pearl: Studies indicate that up to 70-
80% of patients demonstrate suboptimal MDI
technique, even after instruction. Regular re-
The primary challenge with MDIs is the need for hand- education and technique verification are
breath coordination—pressing the canister precisely as essential components of comprehensive
you begin to inhale slowly. Poor technique results in respiratory care.
significant medication wastage, with drug impacting
the throat rather than penetrating deep into the
bronchial tree.
Dry Powder Inhaler (DPI)
Breath-Activated Technology

Dry Powder Inhalers represent a significant technological advancement, eliminating the coordination
requirement inherent to MDIs through a breath-activated mechanism. The medication exists as a finely milled
powder, sometimes combined with larger carrier particles (typically lactose) to improve flow characteristics and
dispersion. When the patient inhales forcefully through the device, the airflow turbulence disaggregates the
powder particles, creating an inhalable aerosol cloud drawn directly into the respiratory tract.

Advantages of DPI Technology Limitations and Considerations

• No propellants required—more environmentally friendly • Requires adequate inspiratory flow rate (typically >30 L/min)
• Breath-activated design eliminates coordination requirements• Not suitable for very young children or elderly with weak
• Compact and discreet for convenient carrying inspiratory effort

• • Ineffective during severe acute asthma when breathing

Dose counters often integrated for adherence monitoring
is severely compromised
• Stable at room temperature with longer shelf life
• Moisture-sensitive—must be stored in dry conditions
• Lactose carrier may be problematic for rare lactose-allergic indiv

Patient selection is crucial: DPIs work best for patients aged 6 years and above with adequate cognitive function to
understand the "quick, deep breath" technique and sufficient inspiratory capacity to generate the necessary airflow.
Soft Mist Inhaler (SMI) and Nebulizers

Soft Mist Inhaler (SMI) Nebulizer Systems

The Soft Mist Inhaler represents the newest generation of handheld inhalation technology, Nebulizers convert liquid medication into a continuous fine mist suitable for inhalation
employing a unique mechanical system that propels liquid medication through a precisely through a face mask or mouthpiece. Two primary types exist: jet nebulizers (using
engineered nozzle system, creating an ultra-fine, slow-moving aerosol cloud. The mist compressed air) and ultrasonic nebulizers (using high-frequency vibrations). Treatment
velocity is approximately 10 times slower than traditional MDI spray, significantly improving typically requires 10-15 minutes of tidal breathing, making it the least demanding technique
lung deposition and reducing oropharyngeal impaction. in terms of patient effort and coordination.
Clinical advantages include: Enhanced lung deposition (up to 50% of emitted dose reaches Ideal clinical scenarios include: Severe acute asthma or COPD exacerbations requiring high-
the lungs versus 10-20% with conventional MDIs), minimal coordination requirements, no dose bronchodilator therapy, young children (under 5 years) unable to use handheld devices,
propellant gases, and suitability for patients with weak inspiratory effort. The extended spray elderly or cognitively impaired patients, hospitalized patients requiring supervised
duration (approximately 1.5 seconds) provides a generous inhalation window. treatment, and delivery of medications not available in MDI or DPI formulations (such as
certain antibiotics or mucolytics).
Particularly valuable for elderly patients, those with severe COPD, and individuals who struggle with Important consideration:
other device types. Nebulizers require electricity or battery power, regular cleaning to
prevent bacterial contamination, and longer treatment times—factors affecting convenience
Advantages of the Inhalation Route
The inhalation route of drug administration offers compelling pharmacological and clinical advantages that have
made it the preferred delivery method for respiratory medications. Understanding these benefits helps clinicians
appreciate why proper inhaler technique is so critical to therapeutic success.

Direct Drug Delivery to Target Tissue Rapid Onset of Action

Medication reaches the bronchial airways and alveoli Bronchodilators begin working within 5-15 minutes of
within seconds of inhalation, bypassing gastrointestinal inhalation during acute symptoms, providing swift relief
absorption and hepatic first-pass metabolism. This from breathlessness and wheezing. This rapid response
targeted delivery achieves therapeutic concentrations is clinically critical during asthma attacks and COPD
precisely where needed whilst minimising systemic drug exacerbations, potentially preventing emergency
exposure and associated adverse effects. department visits and hospitalisations.

Significantly Lower Dose Requirements Reduced Systemic Side Effects

Inhaled medications require only 5-10% of the dose Lower systemic drug levels translate to fewer adverse
needed for equivalent oral therapy. For example, 200 effects such as tremor, tachycardia, electrolyte
micrograms of inhaled salbutamol provides similar disturbances, and adrenal suppression with
bronchodilation to 4-8 milligrams taken orally—a 20-40 corticosteroids. This improved safety profile is
fold reduction in total drug exposure. particularly important for children, elderly patients, and
those requiring chronic daily therapy over many years.
"Proper inhalation technique can mean the difference between effective symptom control and treatment failure. The device is only as go

— Guidelines from the Global Initiative for Asthma (GINA)

 Correct Technique: MDI and DPI
Mastering inhaler technique is fundamental to achieving optimal therapeutic outcomes. Research consistently demonstrates that incorrect
technique is one of the most common reasons for poor asthma and COPD control, leading to unnecessary symptoms, reduced quality of life, and
increased healthcare utilization. Healthcare professionals must not only teach proper technique but also regularly verify and reinforce it at follow-
up visits.
01 02

MDI Technique DPI Technique

Dose Loading: Preparation varies by device—some require twisting
(Turbuhaler), others sliding (Diskus/Accuhaler), and some inserting a
Preparation: Shake the inhaler vigorously for 5-10 seconds to ensure capsule (HandiHaler). Follow device-specific instructions carefully. Never
uniform drug suspension. Remove the protective cap and hold the load the dose until immediately before use.
device upright. Positioning: Exhale fully away from the device (moisture from exhaled
breath can clump the powder). Hold the inhaler horizontally (device-
Positioning: Exhale fully away from the inhaler (to empty the lungs and
specific—some are vertical) and place the mouthpiece in your mouth,
create maximal inspiratory capacity). Place the mouthpiece between
sealing lips tightly.
your teeth, sealing your lips firmly around it. Inhalation: Inhale quickly, forcefully, and deeply—this is not a slow
breath like the MDI, but a rapid, strong inhalation to generate sufficient
Coordination: Begin breathing in slowly through your mouth whilst
turbulence for powder dispersion. You should feel resistance against
simultaneously pressing down firmly on the canister once. This timing is
your inhalation effort.
critical—the actuation must occur as you start inhaling, not before or Completion: Remove the device and hold your breath for approximately
after. 10 seconds. Exhale slowly. Never blow into a DPI at any stage, as
Completion: Continue inhaling slowly and deeply to total lung capacity.
moisture will clump the powder and render subsequent doses
Remove the inhaler and hold your breath for approximately 10 seconds
ineffective.
(or as long as comfortable) to allow particle deposition. Exhale slowly. Verification: With capsule-based DPIs, you can open the device after
Wait
Using30-60 seconds
a Spacer: before
Insert a second
the MDI dose
into the if prescribed.
spacer device, actuate once, inhalation to verify the capsule is empty. Some devices produce a

then immediately inhale slowly and deeply through the spacer whirring sound during inhalation, indicating successful technique.

mouthpiece, or take 5 normal tidal breaths. Spacers dramatically

improve drug delivery and are recommended for all patients, particularly
children and elderly individuals.
 Correct Technique: SMI and Nebulizer
Soft Mist Inhaler (SMI) Technique Nebulizer Technique

Step 1: Place the prescribed liquid medication dose into the nebulizer chamber using a sterile technique. Ensure the volume
Step 1: Hold the inhaler upright with the cap off. Some devices require priming or dose loading—follow manufacturer is appropriate (typically 2-4 mL for optimal nebulization time).
instructions. The device should be at room temperature.
Step 2: Assemble the device correctly—attach tubing securely to both the compressor and nebulizer chamber. Connect the
Step 2: Exhale fully, emptying your lungs completely. Position the mouthpiece in your mouth, creating a tight seal with your face mask (for young children or severe dyspnoea) or mouthpiece (for older children and adults).
lips. Keep the device horizontal or slightly tilted upward.
Step 3: Sit upright in a comfortable position—slouching or lying down reduces lung deposition. Switch on the compressor
Step 3: Press the dose-release button whilst simultaneously beginning a slow, deep inhalation through your mouth. Unlike and verify mist production from the chamber.
DPIs, this should be a slow, controlled breath similar to MDI technique. The mist generation lasts approximately 1.5 seconds
Step 4: Place the mask over nose and mouth or mouthpiece in mouth. Breathe normally with regular tidal breathing—no
—continue inhaling throughout this period.
special breathing pattern is required. Treatment continues until the mist stops, typically 10-15 minutes.
Step 4: Hold your breath for approximately 10 seconds to maximise lung deposition. Exhale slowly through your nose if possible.

Step 5: After completion, wash the chamber and mask/mouthpiece with warm soapy water, rinse thoroughly, and allow to
Key advantage: The SMI's slow-moving mist and extended spray duration make timing much more air dry. This prevents bacterial contamination and maintains device longevity.
forgiving than MDIs, suitable for patients struggling with coordination.
Clinical tip: During severe acute asthma, nebulized bronchodilators can be given continuously or back-to-back for rapid relie
Key Takeaways for Healthcare Professionals
Effective inhaler therapy requires more than simply prescribing the correct medication—it demands a comprehensive approach
encompassing device selection, patient education, technique verification, and ongoing adherence support. Poor inhaler technique
remains a pervasive problem contributing to suboptimal disease control, preventable exacerbations, and unnecessary healthcare costs.

Individualise Device Selection Demonstrate and Verify Technique Educate About Common Errors
Match the device type to the patient's Never assume patients understand Specific mistakes vary by device but
age, cognitive ability, inspiratory written instructions or remember verbal commonly include: inadequate shaking
capacity, and manual dexterity. A device teaching. Physically demonstrate of MDIs, exhaling into devices,
that works excellently for one patient proper technique, then observe the insufficient breath-hold time, poor lip
may be entirely inappropriate for patient performing the technique seal, incorrect inhalation speed (too
another. Consider patient preference— themselves. Identify and correct errors fast for MDIs, too slow for DPIs), and
devices patients find intuitive and immediately. Reassess technique at failing to wait between puffs. Address
convenient are more likely to be used every follow-up visit—even experienced these proactively during teaching
correctly and consistently. patients develop bad habits over time. sessions.

Remember: Wrong inhaler technique is a major cause of poor asthma and COPD control. Regular patient education, technique
demonstration, and verification are not optional extras—they are essential components of competent respiratory care that directly
impact patient outcomes, quality of life, and healthcare resource utilization. Take the time to teach, observe, and reinforce proper
technique at every clinical encounter.

"An inhaler in the hands of a patient who doesn't know how to use it properly is no better than no inhaler at all."